Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
- 65 Downloads
The greatest obstacle in the cure of patients with locally recurrent prostate cancer after radiation therapy is the lack of early detection markers. The majority of patients who are candidates for local salvage therapy have locally advanced disease, precluding successful salvage therapy. A low pretreatment prostate specific antigen (PSA) has shown to be a favorable prognostic variable for disease progression, regardless of the specific local salvage therapy used. Of all the local salvage treatment options for these patients, we believe that salvage radical prostatectomy (RP) offers patients the great-est likelihood of a cure. The salvage RP results approach those achieved with standard RP for patients of similar pathologic stage. When patients are treated early in the course of recurrent disease (preoperative PSA < 10 ng/mL), an estimated two-thirds of patients will be disease-free 5 years after salvage RP alone. With better patient selec-tion and continued technical modifications, the morbidity associated with salvage RP has substantially improved. Perioperative complications approach those observed with standard RP and approximately two-thirds of patients will recover urinary continence. Select patients may also recover functional erections when nerve-sparing techniques are used. Salvage cryotherapy and brachytherapy are minimally invasive alternatives to salvage RP. The cancer control results of these procedures appear to be inferior to results achieved with salvage RP. Each of these procedures is associated with signifi-cant morbidity and do not appear to provide a clear advantage over salvage RP in terms of posttreatment complications, urinary continence, and erectile function. A long-term cure is possible for patients with locally recurrent prostate cancer after radiation therapy. Local salvage therapy must be instituted early to be successful in the course of progressive disease.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 13.Zagars GK, Pollack A, von Eschenbach AC: Prostate can-cer and radiation therapy--the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 1995, 33:23–35. Localization of the site of progressive disease among patients with an increasing PSA level after EBRT.PubMedCrossRefGoogle Scholar
- 19.Cox JD, Gallagher MJ, Hammond EH, et al.: Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Con-sensus Panel. J Clin Oncol 1999, 17:1155.PubMedGoogle Scholar
- 22.Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997, 37:1035–1041.Google Scholar
- 23.Pollack A, Zagars GK, Antolak JA, et al.: Prostate biopsy status and PSA nadir level as early surrogates for treat-ment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys 2002, 54:677–685. Prognostic significance of a positive prostate biopsy 2 years after EBRT.PubMedCrossRefGoogle Scholar
- 25.Eastham JA, Scardino PT: Salvage radical prostatec-tomy: improving outcome after failed radiation ther-apy. Contemp Urol 2004, In press. Analysis of cancer outcome following salvage radical pros-tatectomy alone including long-term cancer-specific sur-vival and multivariable analysis of factors associated with disease progression.Google Scholar
- 35.Stephenson AJ, Scardino PT, Bianco FJ Jr, et al.: Morbid-ity and functional outcomes of salvage radical pros-tatectomy for radiorecurrent prostate cancer. J Urol 2004, In Press. Comprehensive report of the perioperative complications, uri-nary continence results and potency rates associated with sal-vage radical prostatectomy.Google Scholar
- 38.Gheiler EL, Wood DP Jr, Montie JE, Pontes JE: Orthoto-pic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate cancer after definitive radiation therapy. Urol-ogy 1997, 50:580–584.Google Scholar
- 44.Chin JL, Pautler SE, Mouraviev V, et al.: Results of sal-vage cryoablation of the prostate after radiation: iden-tifying predictors of treatment failure and complications. J Urol 2001, 165:1937–1941; discussion 1941-1932. Cancer outcome and complications of salvage cryotherapy using gas-driven cryoprobes.PubMedCrossRefGoogle Scholar
- 45.Leibovich BC, Izawa J, Zincke H, et al.: Recurrent pros-tate cancer after radiation therapy: salvage prostatec-tomy versus salvage cryosurgery. J Urol 2001, 165:1595A.Google Scholar
- 46.Perrotte P, Litwin MS, McGuire EJ, et al.: Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol 1999, 162:398–402. Comprehensive report of the long-term morbidity, urinary continence results and potency rates associated with sal-vage cryotherapy.PubMedCrossRefGoogle Scholar